Related Experiment Video
Updated: Nov 12, 2025

In Vitro Methods for Comparing Target Binding and CDC Induction Between Therapeutic Antibodies: Applications in Biosimilarity Analysis
Published on: May 4, 2017
Testing for similarity of binary efficacy-toxicity responses
Kathrin Möllenhoff1, Holger Dette2, Frank Bretz3
1Department of Mathematics, Ruhr-Universität Bochum, Universitätsstrasse 150, 44801 Bochum, Germany and Department of Mathematics and Computer Science, Eindhoven University of Technology, Groene Loper 3, 5612 AE Eindhoven, The Netherlands.
Abstract:
Clinical trials often aim to compare two groups of patients for efficacy and/or toxicity depending on covariates such as dose. Examples include the comparison of populations from different geographic regions or age classes or, alternatively, of different treatment groups. Similarity of these groups can be claimed if the difference in average outcome is below a certain margin over the entire covariate range. In this article, we consider the problem of testing for similarity in the case that efficacy and toxicity are measured as binary outcome variables. We develop a new test for the assessment of similarity of two groups for a single binary endpoint. Our approach is based on estimating the maximal deviation between the curves describing the responses of the two groups, followed by a parametric bootstrap test. Further, using a two-dimensional Gumbel-type model we develop methodology to establish similarity for (correlated) binary efficacy-toxicity outcomes. We investigate the operating characteristics of the proposed methodology by means of a simulation study and present a case study as an illustration.
Related Concept Videos
Bioequivalence of Drugs: Drugs with Multiple Indications
Dose-Response Relationship: Potency and Efficacy
Bioequivalence Data: Statistical Interpretation
Equivalence: In Vitro and In Vivo Bioequivalence
Bioequivalence studies: Biowaivers
Hazard Ratio
For example, in a clinical trial...

